Get started
Author

Viraj R. Shah

Observed name: V. Shah
OpenAlex ID: A5126525044
Comparative analysis of tirzepatide versus metformin and insulin in type 2 diabetes patients across the 13 most common cancers.
2026 · Viraj R. Shah, Shivam Singh, et al. · Journal of Clinical Oncology · 1
PDF
Impact of GLP1 receptor agonists on severity of prostate cancer at diagnosis: A propensity score weighted analysis.
2026 · Muhammad Ali Khan, Viraj R. Shah, et al. · Journal of Clinical Oncology
County-level educational attainment and long-term outcomes in older men with prostate cancer: A SEER-Medicare 2009–2017 study.
2026 · Viraj R. Shah, Harikrishnan Hyma Kunhiraman, et al. · Journal of Clinical Oncology
Effects of obesity on biphasic immune remodeling of CD45⁺ circulating cells during androgen deprivation therapy in prostate cancer.
2026 · Harikrishnan Hyma Kunhiraman, Priyanshu Nain, et al. · Journal of Clinical Oncology
Association of radiomic skeletal muscle features on prostate T1-weighted MRI with major adverse cardiac events in prostate cancer patients.
2026 · Harikrishnan Hyma Kunhiraman, Sena Azamat, et al. · Journal of Clinical Oncology
Obesity-associated epigenetic remodeling under androgen deprivation therapy: Implications for cardiometabolic risk in prostate cancer.
2026 · Harikrishnan Hyma Kunhiraman, Viraj R. Shah, et al. · Journal of Clinical Oncology
Age as modifier of early proteomic remodeling after androgen deprivation therapy (ADT) in prostate cancer: Influence of innate immune/complement–ECM pathways.
2026 · Harikrishnan Hyma Kunhiraman, Omar M. Elsayed, et al. · Journal of Clinical Oncology
Comparative real-world survival and prescription patterns of darolutamide versus apalutamide in non-metastatic hormone-resistant prostate cancer.
2026 · Muhammad Umar Afzal, Lanyu Mi, et al. · Journal of Clinical Oncology
PDF
Cardio-kidney-metabolic syndrome and prostate cancer: Prognostic significance of higher stages for cardiovascular morbidity and mortality.
2026 · Tarek Nahle, Viraj R. Shah, et al. · Journal of Clinical Oncology
Abstract PS4-09-12: Adverse Social Determinants of Health Are Associated With Lower Rates of Cardiotoxicity Surveillance in Trastuzumab-Treated Breast Cancer Patients
2026 · D. Samat, S. Singh, et al. · Clinical Cancer Research
Works count: 10
Citation count: 1
H-index: 1
I10-index:
Year
Topic
Type